Literature DB >> 11137616

Immunostimulation by bacterial components: I. Activation Of macrophages and enhancement of genetic immunization by the lipopeptide P3CSK4.

U vd Esche1, M Ayoub, S D Pfannes, M R Müller, M Huber, K H Wiesmüller, T Loop, M Humar, K F Fischbach, M Strünkelnberg, P Hoffmann, W G Bessler, K Mittenbühler.   

Abstract

Synthetic lipopeptides derived from the N-terminus of bacterial lipoprotein constitute potent macrophage activators and polyclonal B-lymphocyte stimulators. They are also efficient immunoadjuvants in parenteral, oral and nasal immunization either in combination with or after covalent linkage to an antigen. Here we show how alterations in the molecular structure influence their biological properties indicating P3CSK4 as one of the most active members of a lipopentapeptide fatty acid library. This compound resulted in a most pronounced macrophage stimulation as indicated by NO release, activation of NFkappaB translocation, and enhancement of tyrosine protein phosphorylation. Furthermore, P3CSK4 activates/represses an array of at least 140 genes partly involved in signal transduction and regulation of the immune response. Finally we have evidence that P3CSK4 constitutes an effective adjuvant for DNA immunizations, especially increasing weak humoral immune responses. Our findings are of importance for further optimizing both conventional and genetic immunization, and for the development of novel synthetic vaccines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11137616     DOI: 10.1016/s0192-0561(00)00069-2

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  4 in total

1.  Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses.

Authors:  Lbachir BenMohamed; Radhika Krishnan; Catherine Auge; James F Primus; Don J Diamond
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

2.  Modulation of the bovine delayed-type hypersensitivity responses to defined mycobacterial antigens by a synthetic bacterial lipopeptide.

Authors:  A O Whelan; J C Hope; C J Howard; D Clifford; R G Hewinson; H M Vordermeier
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

3.  Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.

Authors:  D Neil Wedlock; Michel Denis; Gavin F Painter; Gary D Ainge; H Martin Vordermeier; R Glyn Hewinson; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

4.  Effect of phenolic glycolipids from Mycobacterium kansasii on proinflammatory cytokine release. A structure-activity relationship study.

Authors:  Hassan R H Elsaidi; Todd L Lowary
Journal:  Chem Sci       Date:  2015-03-26       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.